A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm

Soluble Epoxide Hydrolase Deficiency Attenuates Neointima Formation in the Femoral Cuff Model of Hyperlipidemic Mice

(2010) Marc Revermann et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation

(2009) Fjoralba Kristo et al.   ATHEROSCLEROSIS

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model

(2009) Jun-Yan Liu et al.   BIOCHEMICAL PHARMACOLOGY

Immune Cells and Molecular Mediators in the Pathogenesis of the Abdominal Aortic Aneurysm

(2009) Konstantinos D. Rizas et al.   Cardiology in Review

Nordihydroguaiaretic Acid Analogues: Their Chemical Synthesis and Biological Activities

(2009) Qingqi Chen   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration

(2009) Eduardo Barbosa-Sicard et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat

(2009) Jun Ma et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats

(2009) Marc Revermann et al.   JOURNAL OF HYPERTENSION

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor  /  Agonist

(2009) S. Naruhn et al.   MOLECULAR PHARMACOLOGY

Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy

(2009) D. Ai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Microsomal Prostaglandin E Synthase-1 Deletion Suppresses Oxidative Stress and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation

(2008) Miao Wang et al.   CIRCULATION

Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

(2008) Arzu Ulu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Leukotriene modifiers in the treatment of cardiovascular diseases

(2008) Graziano Riccioni et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Novel and Potent Inhibitors of 5-Lipoxygenase Product Synthesis Based on the Structure of Pirinixic Acid

(2008) Oliver Werz et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pirinixic Acid Derivatives as Novel Dual Inhibitors of Microsomal Prostaglandin E2Synthase-1 and 5-Lipoxygenase

(2008) Andreas Koeberle et al.   JOURNAL OF MEDICINAL CHEMISTRY

Lipid signalling in disease

(2008) Matthias P. Wymann et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases

(2008) J EVANS et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema?

(2007) S Mittra et al.   BRITISH JOURNAL OF PHARMACOLOGY